Viridian Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VRDN Nasdaq 2836 www.viridiantherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Viridian Therapeutics, Inc.

High Growth Tech Stocks In The US For January 2026 - Jan 15th, 2026 4:38 am
High Growth US Tech Stocks To Watch In January 2026 - Jan 13th, 2026 10:38 am
High Growth Tech Stocks To Watch In The US Market January 2026 - Jan 13th, 2026 4:38 am
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 8th, 2026 2:01 pm
US High Growth Tech Stocks to Watch in January 2026 - Jan 7th, 2026 4:38 am
Viridian Therapeutics Prepares for Transformational 2026 - Jan 6th, 2026 5:01 am
US High Growth Tech Stocks to Watch - Jan 1st, 2026 4:38 am
Exploring US High Growth Tech Stocks In December 2025 - Dec 25th, 2025 4:38 am
Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease - Dec 22nd, 2025 5:00 am
US High Growth Tech: 3 Stocks to Watch - Dec 22nd, 2025 4:38 am
Exploring Three High Growth Tech Stocks In The US Market - Dec 17th, 2025 10:38 am
Argenx Flops, As Viridian Celebrates, On Surprise Setback For Vyvgart Powerhouse - Dec 15th, 2025 2:28 pm
Huge Insider Buying in MGM and Salesforce - Dec 12th, 2025 7:45 am
High Growth Tech Stocks In The US Market With Potential - Dec 11th, 2025 4:38 am
High Growth Tech Stocks to Watch in US December 2025 - Dec 9th, 2025 4:38 am
High Growth Tech Stocks In The US Market To Watch - Dec 2nd, 2025 4:38 am
Exploring 3 High Growth Tech Stocks in the US Market - Nov 25th, 2025 4:38 am
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results - Nov 16th, 2025 8:14 pm
Viridian Therapeutics (VRDN): Examining Valuation After Recent Share Price Surge - Nov 7th, 2025 2:12 pm
Viridian Therapeutics (VRDN) Is Up 16.4% After Revenue Surge and FDA Filing for Veligrotug - Nov 7th, 2025 6:15 am